Sponsors & Exhibitors
***************************************
WARNING: Unauthorised company contacting EUROTOX 2021 industry partners
We have been informed that our EUROTOX 2021 exhibitors and sponsors are facing an increasing number of aggressive marketing calls/emails from unauthorized companies during these days.
We sincerely apologize for any inconveniences!
Please note that the EUROTOX 2021 congress organisation is NOT associated with these companies by any means and has no agreement of any kind with them. We have NOT contracted any of such companies to contact or call our industry partners. We recommend you to not return their calls / emails and to not book any services with them.
If you have any request concerning the EUROTOX 2021 congress, please always contact us as the officially contracted core PCO for EUROTOX 2021: industry@eurotox-congress.com
***************************************
We thank the following sponsors and exhibitors for their generous support (status: September 2021):
Don’t settle for merely keeping your programs going. At Charles River, we’re committed to accelerating your path to IND approvals and product registrations. From strategic planning to flawless execution, we’ll help you mitigate risk, understand complex regulatory requirements, and get your products to market faster than the competition. Expect exquisite science, advanced technologies, and comprehensive services from a dedicated partner who shares your goals, every step of the way.
MultiCASE Inc. is a pioneer in developing software for assessing toxicological and pharmacological potential of chemicals and pharmaceuticals. Research and development is central to us in developing innovative (Q)SAR methodologies and software solutions. The company has maintained strong academic ties in the areas of computational, medicinal, and environmental chemistry.
Helping clients bring life-enhancing products to market faster through innovative solutions such as:
Submit™-The most widely adopted SEND software & services. Submit with confidence while generating value from your SEND data.
KnowledgeScan™ Target Safety Assessment Service – Enabling researchers to make faster, better informed decisions on drug targets.
Provantis® – The leading SaaS solution for preclinical study management.
Leadscope Computational Tox Solutions – Software & services enabling clients to predict chemical safety efficiently & comprehensively.
Genetox Solutions – helping clients to improve integration between data acquisition, auditing and reporting for regulatory genetox assays. Solutions include Comet Assay IV, Cyto Study Manager and Sorcerer Colony Counter
Leading IT Solutions – Leading IT Results.
SEKISUI XenoTech is a specialized global CRO investigating the safety-related properties of novel therapeutics through nonclinical testing. Through our products, services, and resources, SEKISUI XenoTech facilitates development of safer drugs, faster. We offer a comprehensive array of test systems and services relating to metabolism and drug-drug interaction potential.
In vitro specialties include enzyme inhibition and induction, drug transporters, and drug metabolism studies. Our product selection equips customers world-wide to perform their own in vitro studies with high quality test systems. An internal and external consultant network is made available to analyze and contextualize in vitro DDI data and prepare for regulatory submission.
One global company innovating for millions – Covance is now Labcorp for chemical product development. We offer full-service, high quality chemical development services for the global marketplace. From physiochemical testing to human and environmental safety assessment, our comprehensive global capabilities paired with regulatory insights help you achieve your product testing goals. Enjoy a scientific collaboration that brings results – with our committed team of highly-driven, industry-leading specialists who can guide even the most difficult substance through the most complex regulatory requirements.Â
Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. Visit us at https://chemical.labcorp.com/.
Bronze Sponsors
Idiosyncratic drug-induced liver injury (iDILI) represents a major challenge throughout the drug life-span, from pre-clinical discovery through to clinical trials and post-marketing. Consequently the identification and management of iDILI represents a challenge to pre-clinical and clinical researchers, industry and regulators.
The Prospective European Drug-Induced Liver Injury Network (PRO-EURO-DILI) Cost Action represents a unique, co-operative, interdisciplinary European-based DILI network of stakeholders to co-ordinate efforts in DILI, to facilitate bi-directional exchange of discovered knowledge and generated hypotheses among different disciplines, and to promote clinically impactful knowledge discovery and its translation into clinical practice. Please see www.proeurodilinet.eu for more information.
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit.
Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 93 million patients in 130 countries. In 2020, the company generated net sales of EUR 1,359 million.
Discovering, developing and delivering
For almost 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens.
Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.
EFSA is a European agency funded by the European Union that operates independently of the European legislative and executive institutions and EU Member States. It was set up to be a source of scientific advice and communication on risks associated with the food chain.
ATCC supplies cells and microbes to researchers in academia, drug discovery and toxicology and molecular diagnostics. From classic cell lines and bioproducts to more physiologically relevant advanced models, ATCC helps researchers get from bench to bedside with highly-characterized products designed to deliver reproducibility. And its new Genome Portal is adding sequencing data for thousands of microbes, viruses and cells to power new diagnostic assays in the fight for public health.
ATCC is one of the world’s leading biobanks and is proud to support research to overcome COVID-19.
SenzaGen is an innovative biotech company and in vitro CRO that provides research and GLP services for safety assessment of various toxicological endpoints across different industries. Our services help product developing companies to provide safer and more sustainable products to the market and better production environments for employees, while also reducing animal testing.
Our in-house developed GARD® test method combines genomic data from human cells with machine learning for a unique capability to identify and analyze whether a chemical could cause allergic reactions on the skin or in the respiratory tract.
The tests are performed at SenzaGen’s GLP-approved lab and by select partners in Europe and the US.
The Glyphosate Renewal Group (GRG) is a collection of companies seeking the renewal of the EU authorisation of the active substance glyphosate in 2022. To this end, the Glyphosate Renewal Group’s member companies joined resources and efforts to prepare a single dossier with the scientific studies and information on the safety of glyphosate.
Lundbeck is a global pharmaceutical company specialized in developing innovative treatments for brain diseases. For more than 70 years, millions of people have been treated with our products and our development and distribution of pioneering therapies continues to make a difference to people worldwide. We are headquartered in Denmark and located in more than 50 countries around the world. We have production facilities in Denmark, France, and Italy, and research centers in Denmark and US. We employ approximately 5,600 people across the value chain.
Sponsors
Concept Life Sciences is a knowledge and science-led contract research organisation. We are problem-solvers and trusted partners with a proven track record in life sciences, laboratory based analytical testing and mechanistic toxicology. We deliver a comprehensive platform of integrated solutions built on expert knowledge, collaboration, flexibility and extensive in-house resources. Concept Life Sciences was acquired by Spectris Group in 2018.
Eurofins Discovery accelerates the critical drug discovery endeavor for our global clients through decades of experience and flexible solutions. We provide comprehensive services from assay-ready development to DiscoveryOne™ integrated programs; chemistry, in vitro safety and efficacy phenotypic assays, ADME-tox and pre-clinical pharmacology. Whether you require outsourcing needs or perform research in-house, Eurofins Discovery Services and Eurofins DiscoverX product solutions empowers R&D through IND.
TissUse is a Berlin, Germany-based, biotechnology company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse’s Multi-Organ-Chips provide a new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.
TissUse’s Multi-Organ-Chips have been utilized in a large variety of applications including drug development, cosmetics, food and nutrition and consumer products since 2012.
Cyprotex was founded in 1999 and specialises in in vitro and in silico ADME-Tox. The company has sites in the UK and the US. In 2016, Cyprotex was acquired by Evotec AG (www.evotec.com). As a whole, the Group offer integrated and stand-alone drug discovery capabilities as well as full CMC and IND-enabling services, allowing the company to provide expert support across the value chain from early discovery through to preclinical development and beyond.
Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients. The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders. With more than 3,900 highly qualified people at 14 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics. For additional information please go to www.evotec.com and follow us on Twitter @Evotec and LinkedIn.
Emulate develops a breadth of Organ-Chip models with a focus on recreating the microenvironment and mechanical forces cells experience in vivo. Hardware automating media flow and stretch, Bio-Kits including chips and qualified human cells, and a range of standard and custom services are available.
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology.
Exhibitors
in alphabetical order
The current floor plan is available here.
For the preclinical and clinical trial community, Avantor Clinical Services offers an experienced team of skilled associates that has a proven track record of excellence. We ensure that you have the products, processes and pain-point solutions you need – from discovery through delivery – to focus your valuable time on your research and patient outcomes.
Clinical Services includes custom kitting, clinical trial equipment and ancillary supply solutions and biorepository and archiving services.
Avantor – we set science in motion to create a better world.
Concept Life Sciences is a knowledge and science-led contract research organisation. We are problem-solvers and trusted partners with a proven track record in life sciences, laboratory based analytical testing and mechanistic toxicology. We deliver a comprehensive platform of integrated solutions built on expert knowledge, collaboration, flexibility and extensive in-house resources. Concept Life Sciences was acquired by Spectris Group in 2018.
Ellegaard Göttingen Minipigs A/S was founded to supply scientists in biomedical research with a better non-rodent animal model, with many similarities to humans, a high-quality health standard, but also small and easy to handle. Today, Göttingen Minipigs are fully recognized as an established animal model by all regulatory authorities worldwide. From our AAALAC accredited facility in Denmark, we breed Göttingen Minipigs and enable the development of safer and more effective medicines. Based on high health, animal welfare, quality, knowledge, and service Ellegaard Göttingen Minipigs supplies Göttingen Minipigs for biomedical research around the world, in close cooperation with our dedicated partners.
Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. Read more at envigo.com
Eurofins Discovery accelerates the critical drug discovery endeavor for our global clients through decades of experience and flexible solutions. We provide comprehensive services from assay-ready development to DiscoveryOne™ integrated programs; chemistry, in vitro safety and efficacy phenotypic assays, ADME-tox and pre-clinical pharmacology. Whether you require outsourcing needs or perform research in-house, Eurofins Discovery Services and Eurofins DiscoverX product solutions empowers R&D through IND.
Phenion – a Henkel brand – represents 15+ years of competence in skin physiology and in vitro research. Full-Thickness Skin Models, provided in different sizes and formats, reflect pivotal features of human skin, allowing diverse research applications, e. g. genotoxicity assessments (3D Skin Comet Assay). The product portfolio is now complemented with the LONG-LIFE skin model, which allows experiments for up to 50 days, the epiCS, a pure epidermal model, which is OECD-approved for in vitro skin irritation and corrosion testing, skin cells and corresponding culture media.
Our In Silico solutions enable researchers to generate new scientific insights through the identification, extraction and analysis of actionable information.
KnowledgeScan™: Reduces the time and costs of traditional Target Safety Assessment, while maintaining exacting quality standards.
Computational Toxicology Solutions
Supporting a variety of applications including the ICH M7 pharmaceutical impurities guideline, assessment of extractables and leachables, and classification and labelling. Ask about our 2021 software release!
Leadscope Model Applier: Easy-to-use software to apply prediction models, perform an expert review, and create reports.
Predict In Silico Tox service™: helping clients predict chemical safety quickly, efficiently and comprehensively.
Instem Preclinical solutions power the processes that advance your science. Learn about Provantis®, the #1 online solution for GLP & Non-GLP study management – including new features that provide pathologists real-time Insights into their Provantis data.
Come SEND with us – learn how to submit™ with confidence using the market’s most comprehensive and widely adopted SEND study services or our submit™ software suite for creating and visualizing SEND data.
Our Genetic Tox Solutions for image analysis and data management are truly in a class of their own, featuring Comet Assay IV and Cyto Study Manager.
Instem – Leading IT Solutions – Leading IT Results.
One global company innovating for millions – Covance is now Labcorp for chemical product development. We offer full-service, high quality chemical development services for the global marketplace. From physiochemical testing to human and environmental safety assessment, our comprehensive global capabilities paired with regulatory insights help you achieve your product testing goals. Enjoy a scientific collaboration that brings results – with our committed team of highly-driven, industry-leading specialists who can guide even the most difficult substance through the most complex regulatory requirements.Â
Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. Visit us at https://chemical.labcorp.com/.
MatTek In Vitro Life Science Laboratories produces reconstructed 3D human tissue models in Bratislava, Slovakia since 2011. MatTek develops, validates, and implements animal alternative testing methods and innovative 3D reconstructed human tissue models for more than 3 decades. Our EpiDerm and EpiOcular tissue models are used in regulatory toxicology (OECD, EU guidelines) and address toxicology and efficacy concerns throughout the cosmetics, chemical, pharmaceutical, and household product industries. In addition to these two, we have 11 more ready-to-use, highly reproducible reconstructed 3D human tissue models. In 2021, MatTek Corporation was acquired by a bio convergence corporation BICO.
MultiCASE Inc. is a pioneer in developing software for assessing toxicological and pharmacological potential of chemicals and pharmaceuticals. Research and development is central to us in developing innovative (Q)SAR methodologies and software solutions. The company has maintained strong academic ties in the areas of computational, medicinal, and environmental chemistry.
NovaXia is a privately owned, independent contract laboratory specialized in Pathology. Founded in 1996, our laboratory has successfully serviced clients from diverse industry sectors and institutions operating in research and development.
Our mission is to participate and assist in the development of scientific projects by offering a comprehensive range of techniques and skills to execute the best pathology services. We have experience in preparing and evaluating histologic slides from all sort of tissues and species used in non-clinical research and development.
Our objective is to build effective, constructive and trusted, long-term partnerships with our customers. We offer you the flexibility of a medium sized company with the quality standards and certification of a global player.
SEKISUI XenoTech is a specialized global CRO investigating the safety-related properties of novel therapeutics through nonclinical testing. Through our products, services, and resources, SEKISUI XenoTech facilitates development of safer drugs, faster. We offer a comprehensive array of test systems and services relating to metabolism and drug-drug interaction potential.
In vitro specialties include enzyme inhibition and induction, drug transporters, and drug metabolism studies. Our product selection equips customers world-wide to perform their own in vitro studies with high quality test systems. An internal and external consultant network is made available to analyze and contextualize in vitro DDI data and prepare for regulatory submission.
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology.
At STEMCELL, we are driven by our mission to advance scientific progress globally. Our ethically sourced cryopreserved human primary cell portfolio includes products from peripheral blood, cord blood, and bone marrow to streamline your vitro toxicity testing research. Specializing in primary cell-based assays, our in-house Contract Assay Services (CAS) team works with you to design and perform your drug development studies. Our high-quality organoid media and protocols enable the robust establishment, expansion, maintenance, and differentiation of organoids, supporting the incorporation of organoid cultures into your workflows. Learn more at: www.stemcell.com/organoid-products or
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing services company serving the global pharma, biotech, nutrition, animal health, consumer goods and specialty chemical sectors.
Our 4700 scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
With 2 Mn sq ft of specialist discovery, development and manufacturing facilities, Syngene offers dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb and Herbalife. We also work with biotech companies pursuing leading edge science, and MNCs including GSK and Merck KGaA.
TissUse is a Berlin, Germany-based, biotechnology company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse’s Multi-Organ-Chips provide a new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.
TissUse’s Multi-Organ-Chips have been utilized in a large variety of applications including drug development, cosmetics, food and nutrition and consumer products since 2012.
Ushio provides products and development services of microphysiological systems (MPS) or organ(s)-on-a-chip (OoC) to pharmaceutical customers.
In Eurotox2021, We show a new MPS Plate for drug toxicity evaluation in peripheral nerves that developed in collaboration with Prof. Suzuki (Tohoku Institute of Technology).
We also show our service and technology notes for OoC/MPS development.
- Support the development of your MPS/OoC from your objective or concept for drug testing.
- Manufacture MPS/OoC products with high quality and good characteristics that allow obtaining good data on your cell testing.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient, socially responsible and sustainable solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 5,200 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated.
